Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Surgery. 2013 Aug;154(2):179–189. doi: 10.1016/j.surg.2013.03.016

Table 3.

Bivariate Analysis: Factors Associated with Receipt of Preoperative Biliary Stenting

% Undergoing Preoperative Biliary Stenting p-value
Year of Diagnosis <0.0001
 1992–1995 29.6%
 1996–1999 47.1%
 2000–2003 55.9%
 2004–2007 59.1%
Patient Demographics
Sex 0.05
 Male 54.7%
 Female 50.9%
Race 0.04
 White 53.7%
 Black 45.7%
 Hispanic 56.7%
 Other 44.6%
Marital Status 0.21
 Married 53.6%
 Unmarried 51.1%
Charlson comorbidity score 0.36
 0 52.2%
 1 51.0%
 2 55.6%
 3+ 55.8%
Income Quartiles 0.0006
 Quartile 1 (lowest) 45.6%
 Quartile 2 55.6%
 Quartile 3 55.2%
 Quartile 4 (highest) 54.4%
Education Quartiles 0.02
 Quartile 1 (lowest) 47.5%
 Quartile 2 55.6%
 Quartile 3 54.6%
 Quartile 4 (highest) 53.2%
SEER Region <0.0001
 Atlanta 53.4%
 Connecticut 51.0%
 Detroit 44.7%
 Greater California 56.5%
 Hawaii 40.4%
 Iowa 49.2%
 Kentucky 62.0%
 Los Angeles 47.2%
 Louisiana 43.2%
 New Jersey 59.3%
 New Mexico 45.2%
 Rural Georgia 66.7%
 San Francisco 46.5%
 San Jose 51.6%
 Seattle 63.3%
 Utah 64.6%
Preoperative Signs/Symptoms
Jaundice <0.0001
 Yes 66.2%
 No 28.3%
Cholangitis <0.0001
 Yes 87.6%
 No 48.6%
Pruritus <0.0001
 Yes 74.4%
 No 51.1%
Coagulopathy 0.05
 Yes 76.5%
 No 52.5%
Tumor Characteristics and Treatment
Stage (N=2,496) 0.0002
 Localized 44.1%
 Regional 55.0%
 Distant 47.8%
Differentiation 0.49
 Poor 53.7%
Nodal status (regional disease only) (N=1,979) 0.22
 Positive 55.7%
 Negative 52.7%
Neoadjuvant therapy 0.008
 Yes 63.3%
 No 52.0%
Gastroenterologist visit before surgeon visit <0.0001
 Yes 60.7%
 No 41.2%